Lamivudine ViiV: Opinion on medicine for use outside EU
lamivudine
Table of contents
Opinion on medicine for use outside the European Union
Withdrawn opinion
Overview
The opinion for Lamivudine ViiV for use outside the European Union has been withdrawn at the request of the opinion holder.
Opinion details
| Product details | |
|---|---|
| Name of medicinal product |
Lamivudine ViiV
|
| Agency opinion number |
H/W/673
|
| Opinion status |
Withdrawn opinion
|
| Active substance |
lamivudine
|
| International non-proprietary name (INN) or common name |
lamivudine
|
| Therapeutic area (MeSH) |
HIV Infections
|
| Anatomical therapeutic chemical (ATC) code |
J05AF05
|
| Publication details | |
|---|---|
| Opinion holder |
ViiV Healtcare UK Limited |
| Date of opinion |
17/11/2005
|
Product information
17/09/2015 Lamivudine ViiV H-W-673-WS-755
Contents
- Annex I - Summary of product characteristics
- Annex IIA - Manufacturer responsible for batch release
- Annex IIB - Recommendations to the opinion holder - conditions of use
- Annex IIIA - Labelling
- Annex IIIB - Package leaflet
Please note that the size of the above document can exceed 50 pages.
You are therefore advised to be selective about which sections or pages you wish to print.
Pharmacotherapeutic group
Pharmacotherapeutic group
Antivirals for systemic use
Therapeutic indication
Therapeutic indication
Lamivudine is indicated as part of antiretroviral combination therapy for the treatment of human immunodeficiency virus (HIV) infected adults and children.
Assessment history
-
List item
Lamivudine ViiV: Cessation of manufacture - Public statement (PDF/60.66 KB)
First published: 21/12/2015
EMA/847375/2015 -
List item
Lamivudine ViiV : Procedural steps taken and scientific information after opinion (PDF/135 KB)
First published: 02/12/2009
Last updated: 21/12/2015 -
List item
Lamivudine ViiV : Procedural steps taken before scientific opinion (PDF/205.58 KB)
First published: 02/12/2009
Last updated: 21/12/2015 -
List item
Lamivudine ViiV : Scientific discussion (PDF/253.2 KB)
First published: 02/12/2009
Last updated: 21/12/2015 -
List item
Lamivudine ViiV : All presentations (PDF/186.11 KB)
First published: 02/12/2009
Last updated: 21/12/2015